Lucid Diligence Brief - BioPharma

SERB–Hansa Idefirix Deal | Lucid Diligence Brief

SERB’s Idefirix rights acquisition from Hansa Biopharma sharpens its rare…


Artificial_Intelligence

AI in Healthcare and Digital Health Today—May 18, 2026

This week’s AI in Healthcare and Digital Health update highlights…


Privacy Preference Center